Growth Metrics

Prestige Consumer Healthcare (PBH) Cost of Revenue (2016 - 2025)

Prestige Consumer Healthcare has reported Cost of Revenue over the past 16 years, most recently at $126.1 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 1.01% year-over-year to $126.1 million; the TTM value through Dec 2025 reached $484.3 million, down 2.25%, while the annual FY2025 figure was $503.3 million, 2.13% up from the prior year.
  • Cost of Revenue for Q4 2025 was $126.1 million at Prestige Consumer Healthcare, up from $122.5 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $130.3 million in Q1 2023 and troughed at $105.3 million in Q1 2021.
  • A 5-year average of $121.1 million and a median of $122.9 million in 2023 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: grew 19.69% in 2021 and later dropped 8.0% in 2025.
  • Year by year, Cost of Revenue stood at $117.6 million in 2021, then rose by 6.39% to $125.1 million in 2022, then fell by 1.86% to $122.8 million in 2023, then increased by 3.72% to $127.4 million in 2024, then decreased by 1.01% to $126.1 million in 2025.
  • Business Quant data shows Cost of Revenue for PBH at $126.1 million in Q4 2025, $122.5 million in Q3 2025, and $109.2 million in Q2 2025.